{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:38:14Z","timestamp":1792528694349,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":287,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011680","name":"King Fahad Medical City","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011680","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101494","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:35:39Z","timestamp":1792442139000},"page":"101494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeted redox gene-expression profiling reveals shared and distinct expression patterns in HBV- and HCV-associated hepatocellular carcinoma"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6761-9519","authenticated-orcid":false,"given":"Halah Z.","family":"Al-Rawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihan Mesfer","family":"Al-Ghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadeel","family":"Alsaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reham M.","family":"Alahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Budur Mohammed M.","family":"Albariqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4116-1633","authenticated-orcid":false,"given":"Amna","family":"Ghazafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaima F.","family":"Al-Shammari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afnan H.","family":"Al-Ghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bdoor Ghareeb","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowa Jamal Aldeen","family":"Siddiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1270-2216","authenticated-orcid":false,"given":"Maaweya","family":"Awadalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ctarc.2026.101494_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2025.101571","article-title":"Hepatocellular carcinoma: epidemiology, diagnosis and treatment","volume":"7","author":"Mauro","year":"2025","journal-title":"JHEP Reports"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101494_bib0002","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ctarc.2026.101494_bib0003","doi-asserted-by":"crossref","unstructured":"N. Amin, J. Anwar, A. Sulaiman, N. N. Naumova, and N. Anwar, \"Hepatocellular Carcinoma: A Comprehensive Review,\" Diseases, vol. 13, no. 7, p. 207 10.3390\/diseases13070207.","DOI":"10.3390\/diseases13070207"},{"issue":"Suppl","key":"10.1016\/j.ctarc.2026.101494_bib0004","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.3350\/cmh.2024.0824","article-title":"Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment","volume":"31","author":"Hwang","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101494_bib0005","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12943-025-02378-8","article-title":"The tumor microenvironment in hepatocellular carcinoma: mechanistic insights and therapeutic potential of traditional Chinese medicine","volume":"24","author":"Su","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ctarc.2026.101494_bib0006","doi-asserted-by":"crossref","unstructured":"C. Volponi, A. Gazzillo, and E. Bonavita, \"The Tumor Microenvironment of Hepatocellular Carcinoma: Untying an Intricate Immunological Network,\" Cancers, vol. 14, no. 24, p. 6151 10.3390\/cancers14246151.","DOI":"10.3390\/cancers14246151"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101494_bib0007","doi-asserted-by":"crossref","first-page":"026","DOI":"10.1055\/s-0038-1676806","article-title":"Inflammation and liver cancer: molecular mechanisms and therapeutic targets","volume":"39","author":"Yang","year":"2019","journal-title":"Semin. Liver. Dis."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101494_bib0008","doi-asserted-by":"crossref","DOI":"10.1111\/eci.70132","article-title":"Metabolic dysfunction-associated steatotic liver disease, insulin resistance and hepatocellular carcinoma: a deadly triad","volume":"56","author":"Caturano","year":"2026","journal-title":"Eur. J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101494_bib0009","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-026-15893-8","article-title":"Efficacy and safety of immune-based combinations in metastatic hepatocellular carcinoma: a systematic review and network meta-analysis","volume":"26","author":"de Moura","year":"2026","journal-title":"BMC. Cancer"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101494_bib0010","first-page":"352","article-title":"Associations between \"cancer risk\", \"inflammation\" and \"metabolic syndrome\": a scoping review","volume":"13","author":"Vitale","year":"2024","journal-title":"Biology. (Basel)"},{"key":"10.1016\/j.ctarc.2026.101494_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.116021","article-title":"Targeting metabolic reprogramming in hepatocellular carcinoma to overcome therapeutic resistance: a comprehensive review","volume":"170","author":"Wang","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ctarc.2026.101494_bib0012","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.2147\/JIR.S435316","article-title":"Chronic inflammatory and immune microenvironment promote hepatocellular carcinoma evolution","volume":"Volume 16","author":"Chen","year":"2023","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.ctarc.2026.101494_bib0013","article-title":"Metabolic rearrangements and intratumoral heterogeneity for immune response in hepatocellular carcinoma","volume":"14","author":"Xu","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101494_bib0014","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00018-025-05812-8","article-title":"Ferroptosis in cancer: revealing the multifaceted functions of mitochondria","volume":"82","author":"Ding","year":"2025","journal-title":"Cell Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101494_bib0015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.ctarc.2026.101494_bib0016","doi-asserted-by":"crossref","unstructured":"D. Quaranto et al., \"Ferroptosis\u2014The \u201cDouble-Edged Sword\u201d in Cancer: Mechanisms of Tumor Suppression\/Resistance and Therapeutic Manipulation,\" Biology, vol. 15, no. 1, p. 67 10.3390\/biology15010067.","DOI":"10.3390\/biology15010067"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101494_bib0017","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.7150\/ijbs.96014","article-title":"Current progress of ferroptosis study in hepatocellular carcinoma","volume":"20","author":"Zhu","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101494_bib0018","doi-asserted-by":"crossref","DOI":"10.1111\/jvh.70092","article-title":"HBV dominance is associated with a distinct inflammatory milieu in HBV\/HCV coinfection","volume":"32","author":"Oltmanns","year":"2025","journal-title":"J. Viral. Hepat."},{"key":"10.1016\/j.ctarc.2026.101494_bib0019","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02048","article-title":"HBV-induced immune imbalance in the development of HCC","volume":"10","author":"Chen","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101494_bib0020","doi-asserted-by":"crossref","DOI":"10.1111\/liv.16202","article-title":"HBV-induced carcinogenesis: mechanisms, correlation with viral suppression, and implications for treatment","volume":"45","author":"Tu","year":"2025","journal-title":"Liver. Int."},{"key":"10.1016\/j.ctarc.2026.101494_bib0021","doi-asserted-by":"crossref","DOI":"10.1111\/eci.70132","article-title":"Metabolic dysfunction-associated steatotic liver disease, insulin resistance and hepatocellular carcinoma: a deadly triad","volume":"56","author":"Caturano","year":"2026","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.ctarc.2026.101494_bib0022","doi-asserted-by":"crossref","unstructured":"T. Nakamura et al., \"Pathogenic Mechanisms of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Associated Hepatocellular Carcinoma,\" Cells, vol. 14, no. 6, p. 428 10.3390\/cells14060428.","DOI":"10.3390\/cells14060428"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101494_bib0023","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/14712598.2026.2642273","article-title":"Nivolumab plus ipilimumab for hepatocellular carcinoma: a game-changer?","volume":"26","author":"Di Marco","year":"2026","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"20","key":"10.1016\/j.ctarc.2026.101494_bib0024","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252011091","article-title":"Hepatocellular carcinoma immunotherapy: predictors of response, issues, and challenges","volume":"25","author":"Rizzo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ctarc.2026.101494_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1191074","article-title":"Single cell and bulk transcriptome analysis identified oxidative stress response-related features of Hepatocellular Carcinoma","volume":"11","author":"Zhang","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ctarc.2026.101494_bib0026","article-title":"Tumor-associated bacteria activate PRDX1-driven glycolysis to promote immune evasion and PD-1 antibody resistance in hepatocellular carcinoma,\" (lish)","volume":"16 - 2025","author":"Zhang","year":"2025","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101494_bib0027","article-title":"Identification of ferroptosis-related genes for overall survival prediction in hepatocellular carcinoma","volume":"12","author":"Luo","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ctarc.2026.101494_bib0028","doi-asserted-by":"crossref","unstructured":"J. Lee and J.-L. Roh, \"Ferroptosis in Oral Cancer: Mechanistic Insights and Clinical Prospects,\" Cells, vol. 14, no. 21, p. 1685 doi: 10.3390\/cells14211685.","DOI":"10.3390\/cells14211685"},{"key":"10.1016\/j.ctarc.2026.101494_bib0029","article-title":"Ferroptosis and hepatocellular carcinoma: the emerging role of lncRNAs","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101494_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1677089","article-title":"A lactylation-ferroptosis cross-talk gene signature predicts hepatocellular carcinoma prognosis and reveals STMN1\/PRDX1 as therapeutic targets","volume":"16","author":"Meng","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101494_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117769","article-title":"Ferroptosis in hepatocellular carcinoma: mechanisms and therapeutic implications","volume":"182","author":"Tu","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ctarc.2026.101494_bib0032","article-title":"Ferroptosis, pathogenesis and therapy in AS co-depression disease","volume":"16","author":"Zhao","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ctarc.2026.101494_bib0033","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s12015-025-11016-1","article-title":"Regulating ferroptosis in leukemic stem cells: from stemness preservation to targeted differentiation strategies","volume":"22","author":"Wang","year":"2026","journal-title":"Stem Cell Rev. Rep."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101494_bib0034","article-title":"Molecular mechanisms of ferroptosis and its role in pulmonary disease","volume":"2020","author":"Tao","year":"2020","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.ctarc.2026.101494_bib0035","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.bioorg.2019.02.036","article-title":"Pyrazoles containing thiophene, thienopyrimidine and thienotriazolopyrimidine as COX-2 selective inhibitors: design, synthesis, in vivo anti-inflammatory activity, docking and in silico chemo-informatic studies","volume":"85","author":"El-Shoukrofy","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ctarc.2026.101494_bib0036","doi-asserted-by":"crossref","unstructured":"P. Tziona, P. Theodosis-Nobelos, D. Lepesiotis, A. Gavalas, and E. A. Rekka, \"Nitrogen Monoxide Releasing Nitric Ester Derivatives of Ibuprofen and Naproxen as COX Inhibitors, Anti-Inflammatory and Hypolipidemic Compounds,\" Molecules, vol. 30, no. 18, p. 3744 doi: 10.3390\/molecules30183744.","DOI":"10.3390\/molecules30183744"},{"issue":"13","key":"10.1016\/j.ctarc.2026.101494_bib0037","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.7150\/ijbs.86492","article-title":"The PTGS2\/COX2-PGE(2) signaling cascade in inflammation: pro or anti? A case study with type 1 diabetes mellitus","volume":"19","author":"Mart\u00edn-V\u00e1zquez","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ctarc.2026.101494_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1556956","article-title":"Divergent gene expression of PTGS1 and PTGS2 along the disease course of chronic myeloid leukaemia","volume":"15","author":"Wosniaki","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ctarc.2026.101494_bib0039","doi-asserted-by":"crossref","unstructured":"N. R. Selvaraj, D. Nandan, B. G. Nair, V. A. Nair, P. Venugopal, and R. Aradhya, \"Oxidative Stress and Redox Imbalance: Common Mechanisms in Cancer Stem Cells and Neurodegenerative Diseases,\" Cells, vol. 14, no. 7, p. 511 10.3390\/cells14070511.","DOI":"10.3390\/cells14070511"},{"issue":"17","key":"10.1016\/j.ctarc.2026.101494_bib0040","doi-asserted-by":"crossref","first-page":"11632","DOI":"10.1021\/acs.jmedchem.3c00770","article-title":"NADPH oxidases: from molecular mechanisms to current inhibitors","volume":"66","author":"Cipriano","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ctarc.2026.101494_bib0041","doi-asserted-by":"crossref","unstructured":"V. Ngo and M. L. Duennwald, \"Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease,\" Antioxidants, vol. 11, no. 12, p. 2345 10.3390\/antiox11122345.","DOI":"10.3390\/antiox11122345"},{"issue":"10","key":"10.1016\/j.ctarc.2026.101494_bib0042","doi-asserted-by":"crossref","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","article-title":"ROS function in redox signaling and oxidative stress","volume":"24","author":"Schieber","year":"2014","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ctarc.2026.101494_bib0043","doi-asserted-by":"crossref","unstructured":"E. Desideri, S. Castelli, and M. R. Ciriolo, \"MAPK Signaling in the Interplay Between Oxidative Stress and Autophagy,\" Antioxidants, vol. 14, no. 6, p. 662 doi: 10.3390\/antiox14060662.","DOI":"10.3390\/antiox14060662"},{"key":"10.1016\/j.ctarc.2026.101494_bib0044","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.39159","article-title":"Deficit of mitogen-activated protein kinase phosphatase 1 (DUSP1) accelerates progressive hearing loss","volume":"8","author":"Celaya","year":"2019","journal-title":"Elife"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101494_bib0045","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.21037\/tcr-24-2155","article-title":"Evaluating HSP90AA1 as a predictive biomarker for prognosis in lung adenocarcinoma","volume":"14","author":"Xiang","year":"2025","journal-title":"Transl. Cancer Res."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101494_bib0046","doi-asserted-by":"crossref","first-page":"787","DOI":"10.32604\/or.2023.030081","article-title":"HSP90AA1 promotes lymphatic metastasis of hypopharyngeal squamous cell carcinoma by regulating epithelial-mesenchymal transition","volume":"31","author":"Tang","year":"2023","journal-title":"Oncol. Res."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101494_bib0047","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s13046-018-0880-6","article-title":"HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma","volume":"37","author":"Xiao","year":"2018","journal-title":"J. Exper. Clin. Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101494_bib0048","doi-asserted-by":"crossref","unstructured":"Z. Wali, Neha, A. Shamsi, S. Tasqeruddin, and S. Anwar, \"The SPINK Protein Family in Cancer: Emerging Roles in Tumor Progression, Therapeutic Resistance, and Precision Oncology,\" Pharmaceuticals, vol. 18, no. 8, p. 1194 doi: 10.3390\/ph18081194.","DOI":"10.3390\/ph18081194"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101494_bib0049","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40246-025-00740-x","article-title":"Genetics and clinical implications of SPINK1 in the pancreatitis continuum and pancreatic cancer","volume":"19","author":"Wang","year":"2025","journal-title":"Hum. Genomics."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101494_bib0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s43556-023-00142-2","article-title":"The mechanism of ferroptosis and its related diseases","volume":"4","author":"Feng","year":"2023","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.ctarc.2026.101494_bib0051","article-title":"Evaluation of genes and molecular pathways involved in ferroptosis in breast cancer: a systems biology and bioinformatics approach","volume":"44","author":"Heydari","year":"2025","journal-title":"Biochem. Biophys. Rep."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101494_bib0052","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12672-023-00849-2","article-title":"Machine learning and experiments identifies SPINK1 as a candidate diagnostic and prognostic biomarker for hepatocellular carcinoma","volume":"14","author":"Yi","year":"2023","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.ctarc.2026.101494_bib0053","doi-asserted-by":"crossref","unstructured":"E. Turlej, A. Domaradzka, J. Radzka, D. Drulis-Fajdasz, J. Kulbacka, and A. Gizak, \"Cross-Talk Between Cancer and Its Cellular Environment\u2014A Role in Cancer Progression,\" Cells, vol. 14, no. 6, p. 403 10.3390\/cells14060403.","DOI":"10.3390\/cells14060403"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101494_bib0054","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202300050RR","article-title":"Thioredoxin facilitates hepatocellular carcinoma stemness and metastasis by increasing BACH1 stability to activate the AKT\/mTOR pathway","volume":"37","author":"Wang","year":"2023","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101494_bib0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00204-025-04146-5","article-title":"Interplay of oxidative stress and antioxidant mechanisms in cancer development and progression","volume":"100","author":"Jomova","year":"2026","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ctarc.2026.101494_bib0056","doi-asserted-by":"crossref","unstructured":"D. Sorriento, \"Oxidative Stress and Inflammation in Cancer,\" Antioxidants, vol. 13, no. 11, p. 1403 10.3390\/antiox13111403.","DOI":"10.3390\/antiox13111403"},{"key":"10.1016\/j.ctarc.2026.101494_bib0057","doi-asserted-by":"crossref","unstructured":"Y. Hong, A. Boiti, D. Vallone, and N. S. Foulkes, \"Reactive Oxygen Species Signaling and Oxidative Stress: Transcriptional Regulation and Evolution,\" Antioxidants, vol. 13, no. 3, p. 312 doi: 10.3390\/antiox13030312.","DOI":"10.3390\/antiox13030312"},{"key":"10.1016\/j.ctarc.2026.101494_bib0058","doi-asserted-by":"crossref","unstructured":"L. Conde de la Rosa, L. Goicoechea, S. Torres, C. Garcia-Ruiz, and J. C. Fernandez-Checa, \"Role of Oxidative Stress in Liver Disorders,\" Livers, vol. 2, no. 4, pp. 283-314 doi: 10.3390\/livers2040023.","DOI":"10.3390\/livers2040023"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101494_bib0059","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.70107","article-title":"Reactive oxygen species (ROS) and their profound influence on regulating diverse aspects of cancer: a concise review","volume":"86","author":"Tiwari","year":"2025","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ctarc.2026.101494_bib0060","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/1743-422X-10-251","article-title":"Oxidative stress and hepatitis C virus","volume":"10","author":"Paracha","year":"2013","journal-title":"Virol. J."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101494_bib0061","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4103\/1319-3767.103429","article-title":"Persistent oxidative stress in patients with chronic active Hepatitis-C infection after antiviral therapy failure","volume":"18","author":"El-Kannishy","year":"2012","journal-title":"Saudi. J. Gastroenterol."},{"key":"10.1016\/j.ctarc.2026.101494_bib0062","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1479-5876-9-171","article-title":"Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview","volume":"9","author":"Marra","year":"2011","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ctarc.2026.101494_bib0063","doi-asserted-by":"crossref","unstructured":"Z. Chen, J. Fan, X. Chen, K. Yang, and K. Wang, \"Oxidative Stress and Redox Signaling in Gastric Cancer: From Mechanisms to Therapeutic Implications,\" Antioxidants, vol. 14, no. 3, p. 258 doi: 10.3390\/antiox14030258.","DOI":"10.3390\/antiox14030258"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246829422600403X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246829422600403X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:40:30Z","timestamp":1792525230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246829422600403X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":63,"alternative-id":["S246829422600403X"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101494","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted redox gene-expression profiling reveals shared and distinct expression patterns in HBV- and HCV-associated hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101494","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101494"}}